XML 49 R38.htm IDEA: XBRL DOCUMENT
v3.22.2

ACQUISITION–RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Acquisition-related Restructuring and Discontinuation Costs | Acquisition-related (gains) charges, product discontinuation and other for the three and six months ended June 30, 2022 and 2021 summarized below (in thousands):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Severance-related expenses | $ | 950 |  |  | $ | — |  |  | $ | 4,065 |  |  | $ | — |
Acquisition-related fees | 2,168 |  |  | 7 |  |  | 4,013 |  |  | 7 |
Other acquisition expenses | 104 |  |  | — |  |  | 552 |  |  | — |
Total acquisition-related charges | 3,222 |  |  | 7 |  |  | 8,630 |  |  | 7 |
Flexion contingent consideration | (12,523) |  |  | — |  |  | (13,317) |  |  | — |
MyoScience contingent consideration | (8,757) |  |  | 139 |  |  | (9,034) |  |  | (988) |
Nuance Biotech Co. Ltd. agreement dissolution costs | — |  |  | — |  |  | — |  |  | 3,000 |
Total acquisition-related (gains) charges, product discontinuation and other | $ | (18,058) |  |  | $ | 146 |  |  | $ | (13,721) |  |  | $ | 2,019 |

X
- Definition COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block] + References No definition available. + Details
Name: | pcrx_COMMERCIALPARTNERSANDOTHERAGREEMENTSTableTextBlock
Namespace Prefix: | pcrx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration